HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Claire Fabre Selected Research

Proteasome Endopeptidase Complex (Proteasome)

12/2012New proteasome inhibitors in myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Claire Fabre Research Topics

Disease

14Neoplasms (Cancer)
11/2023 - 08/2004
7Multiple Myeloma
08/2013 - 10/2010
4Myelodysplastic Syndromes (Myelodysplastic Syndrome)
09/2008 - 06/2007
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
09/2008 - 02/2008
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2023 - 02/2008
2Uveal melanoma
05/2023 - 01/2020
2Thrombocytopenia (Thrombopenia)
01/2022 - 01/2021
1Colorectal Neoplasms (Colorectal Cancer)
11/2023
1Renal Cell Carcinoma (Grawitz Tumor)
11/2023
1Leukemia
03/2022
1Liposarcoma
01/2022
1Esophageal Squamous Cell Carcinoma
01/2022
1Squamous Cell Carcinoma of Head and Neck
01/2022
1Disease Progression
01/2022
1Genomic Instability
01/2021
1Osteosarcoma (Osteogenic Sarcoma)
01/2021
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
11/2014
1Hematologic Neoplasms (Hematological Malignancy)
08/2013
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
12/2012
1Polyploidy
06/2007
1Starvation
11/2005
1Lymphoma (Lymphomas)
08/2004

Drug/Important Bio-Agent (IBA)

5Transcription Factors (Transcription Factor)IBA
01/2021 - 07/2008
4siremadlinIBA
03/2022 - 01/2021
2Drug CombinationsIBA
05/2023 - 01/2020
2Antineoplastic Agents (Antineoplastics)IBA
01/2021 - 08/2013
2Rituximab (Mabthera)FDA Link
11/2014 - 08/2004
2Bortezomib (Velcade)FDA Link
12/2012 - 09/2012
1NIS-793IBA
11/2023
1spartalizumabIBA
11/2023
1B7-H1 AntigenIBA
11/2023
1Monoclonal AntibodiesIBA
11/2023
1Cadherins (E-Cadherin)IBA
01/2022
1ribociclibIBA
01/2022
1CyclinsIBA
01/2022
1Immunoconjugates (Immunoconjugate)IBA
01/2022
1Biomarkers (Surrogate Marker)IBA
01/2021
1Blocking AntibodiesIBA
01/2021
1NVP-CGM097IBA
01/2021
1Immune Checkpoint InhibitorsIBA
01/2021
1AntigensIBA
01/2021
1Growth Differentiation Factor 15IBA
01/2021
1InterferonsIBA
12/2020
1CLR457IBA
01/2019
1Glucose (Dextrose)FDA LinkGeneric
01/2019
1Cyclin-Dependent Kinases (cdk Proteins)IBA
11/2014
1dinaciclibIBA
11/2014
1Histone Deacetylase InhibitorsIBA
08/2013
1Immunoglobulins (Immunoglobulin)IBA
08/2013
1DNA (Deoxyribonucleic Acid)IBA
01/2013
1Proteasome InhibitorsIBA
12/2012
1Proteasome Endopeptidase Complex (Proteasome)IBA
12/2012
1PBS-1086IBA
09/2012
1Proteins (Proteins, Gene)FDA Link
06/2012
1Lenalidomide (CC 5013)FDA Link
10/2010
1pomalidomideIBA
10/2010
1CytokinesIBA
10/2010
1Erlotinib Hydrochloride (CP 358,774)FDA Link
02/2008
1ErbB Receptors (EGF Receptor)IBA
02/2008
1Caspase 3 (Caspase-3)IBA
06/2007
1CaspasesIBA
06/2007
1NF-kappa B (NF-kB)IBA
11/2005
1PK 11195 (PK11195)IBA
11/2005
1Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA
08/2004
1AcidsIBA
08/2004

Therapy/Procedure

5Therapeutics
05/2023 - 12/2012
2Immunotherapy
01/2021 - 12/2020
1Regimen B
01/2022
1Stem Cell Transplantation
04/2012
1Homologous Transplantation
04/2012
1Drug Therapy (Chemotherapy)
08/2004